Thompson Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.39M | Hold |
5,765
| – | – | 0.16% | 104 |
|
|
2026
Q1 | $1.09M | Hold |
5,765
| – | – | 0.14% | 100 |
|
|
2025
Q4 | $980K | Sell |
5,765
-805
| -12% | -$123K | 0.12% | 101 |
|
|
2025
Q3 | $866K | Buy |
6,570
+550
| +9% | +$66K | 0.12% | 107 |
|
|
2025
Q2 | $639K | Hold |
6,020
| – | – | 0.09% | 113 |
|
|
2025
Q1 | $747K | Sell |
6,020
-1,200
| -17% | -$157K | 0.11% | 108 |
|
|
2024
Q4 | $889K | Buy |
7,220
+550
| +8% | +$64.8K | 0.13% | 107 |
|
|
2024
Q3 | $743K | Hold |
6,670
| – | – | 0.11% | 107 |
|
|
2024
Q2 | $712K | Hold |
6,670
| – | – | 0.11% | 105 |
|
|
2024
Q1 | $803K | Buy |
6,670
+150
| +2% | +$18.4K | 0.12% | 104 |
|
|
2023
Q4 | $802K | Buy |
6,520
+1,300
| +25% | +$162K | 0.13% | 105 |
|
|
2023
Q3 | $676K | Hold |
5,220
| – | – | 0.12% | 106 |
|
|
2023
Q2 | $647K | Hold |
5,220
| – | – | 0.11% | 117 |
|
|
2023
Q1 | $764K | Sell |
5,220
-250
| -5% | -$37K | 0.13% | 109 |
|
|
2022
Q4 | $871K | Sell |
5,470
-1,325
| -19% | -$194K | 0.16% | 104 |
|
|
2022
Q3 | $906K | Hold |
6,795
| – | – | 0.18% | 102 |
|
|
2022
Q2 | $1.06M | Sell |
6,795
-1,550
| -19% | -$239K | 0.18% | 99 |
|
|
2022
Q1 | $1.3M | Hold |
8,345
| – | – | 0.19% | 99 |
|
|
2021
Q4 | $1.06M | Buy |
8,345
+225
| +3% | +$29.6K | 0.15% | 111 |
|
|
2021
Q3 | $1.06M | Buy |
8,120
+1,900
| +31% | +$287K | 0.16% | 106 |
|
|
2021
Q2 | $1.1M | Hold |
6,220
| – | – | 0.16% | 108 |
|
|
2021
Q1 | $1.02M | Hold |
6,220
| – | – | 0.15% | 108 |
|
|
2020
Q4 | $1.03M | Hold |
6,220
| – | – | 0.17% | 105 |
|
|
2020
Q3 | $887K | Buy |
6,220
+650
| +12% | +$80.6K | 0.17% | 106 |
|
|
2020
Q2 | $615K | Hold |
5,570
| – | – | 0.12% | 116 |
|
|
2020
Q1 | $556K | Buy |
5,570
+300
| +6% | +$38.8K | 0.12% | 113 |
|
|
2019
Q4 | $787K | Sell |
5,270
-675
| -11% | -$91.9K | 0.13% | 108 |
|
|
2019
Q3 | $762K | Hold |
5,945
| – | – | 0.15% | 103 |
|
|
2019
Q2 | $848K | Hold |
5,945
| – | – | 0.17% | 101 |
|
|
2019
Q1 | $850K | Buy |
5,945
+1,045
| +21% | +$136K | 0.16% | 102 |
|
|
2018
Q4 | $607K | Sell |
4,900
-175
| -3% | -$26K | 0.14% | 105 |
|
|
2018
Q3 | $853K | Sell |
5,075
-625
| -11% | -$107K | 0.15% | 98 |
|
|
2018
Q2 | $982K | Sell |
5,700
-100
| -2% | -$16.3K | 0.18% | 96 |
|
|
2018
Q1 | $876K | Hold |
5,800
| – | – | 0.16% | 99 |
|
|
2017
Q4 | $781K | Hold |
5,800
| – | – | 0.14% | 105 |
|
|
2017
Q3 | $848K | Hold |
5,800
| – | – | 0.16% | 100 |
|
|
2017
Q2 | $902K | Sell |
5,800
-325
| -5% | -$49.7K | 0.17% | 98 |
|
|
2017
Q1 | $889K | Sell |
6,125
-625
| -9% | -$81.4K | 0.17% | 98 |
|
|
2016
Q4 | $736K | Buy |
6,750
+2,950
| +78% | +$329K | 0.14% | 104 |
|
|
2016
Q3 | $462K | Buy |
3,800
+300
| +9% | +$40.4K | 0.09% | 121 |
|
|
2016
Q2 | $495K | Hold |
3,500
| – | – | 0.1% | 114 |
|
|
2016
Q1 | $457K | Buy |
3,500
+750
| +27% | +$93.4K | 0.1% | 115 |
|
|
2015
Q4 | $387K | Buy |
2,750
+350
| +15% | +$48.5K | 0.08% | 127 |
|
|
2015
Q3 | $319K | Buy |
2,400
+100
| +4% | +$17.2K | 0.07% | 137 |
|
|
2015
Q2 | $405K | Buy |
+2,300
| New | +$413K | 0.08% | 124 |
|
Other funds holding JAZZ
Thompson Investment Management's JAZZ Position: Q2 2026 in Review
Thompson Investment Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 5,765 shares worth $1.39M. The position accounts for 0.16% of the portfolio, ranked #104.
Thompson Investment Management first reported a position in JAZZ in Q2 2015 and has held it in 45 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Thompson Investment Management held 5,765 shares of Jazz Pharmaceuticals worth $1.39M as of Q2 2026.
- Thompson Investment Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
- Jazz Pharmaceuticals made up 0.16% of Thompson Investment Management's portfolio in Q2 2026, its #104 holding.
- Thompson Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2015 and has held it in 45 quarters since.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.